Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Oral tazarotene shows sustained efficacy in psoriasis
Washington - Oral tazarotene has sustained efficacy in the treatment of moderate to very severe plaque psoriasis with no cumulative toxicity. Alan Menter, M.D., presented data from a one-year, open-label study at the 62nd annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
